Metronidazole clinical pharmacology

Revision as of 00:28, 9 January 2014 by Chetan Lokhande (talk | contribs) (Replaced content with "__NOTOC__ {{Metronidazole }} {{CMG}}; {{AE}} {{chetan}} <ref name="dailymed.nlm.nih.gov">{{Cite web | last = | first = | title = FLAGYL (METRONIDAZOLE) CAPSULE [G.D. ...")
Jump to navigation Jump to search
Metronidazole
Flagyl® FDA Package Insert
Description
Clinical Pharmacology
Microbiology
Indications and Usage
Contraindications
Warnings and Precautions
Adverse Reactions
Drug Interactions
Overdosage
Dosage and Administration
How Supplied
Labels and Packages

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Chetan Lokhande, M.B.B.S [2]


[1]


References

  1. ↑ "FLAGYL (METRONIDAZOLE) CAPSULE [G.D. SEARLE LLC DIVISION OF PFIZER INC]".

Adapted from the FDA Package Insert.

Retrieved from "https://www.wikidoc.org/index.php?title=Metronidazole_clinical_pharmacology&oldid=928943"